共 8 条
[2]
A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance[J] . Hao Zheng,Shilin Li,Liang Ma,Ling Cheng,Chongyang Deng,Zhizhi Chen,Caifeng Xie,Mingli Xiang,Wei Jiang,Lijuan Chen. European Journal of Pharmacology . 2011 (2)
[4]
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis[J] . Free Radical Biology and Medicine . 2011 (1)
[6]
Oxidative protein folding in the endoplasmic reticulum: Tight links to the mitochondria-associated membrane (MAM)[J] . Thomas Simmen,Emily M. Lynes,Kevin Gesson,Gary Thomas. BBA - Biomembranes . 2010 (8)
[7]
Epidemiology of non-alcoholic fatty liver disease in China[J] . Jian-Gao Fan,Geoffrey C. Farrell. Journal of Hepatology . 2008 (1)
[8]
Steatohepatitis: A tale of two “hits”?[J] . Christopher P. Day,Oliver F.W. James. Gastroenterology . 1998 (4)